Who invested in ArriVent BioPharma?
2 investors are on record as having backed ArriVent BioPharma — Develops precision medicines for cancer and serious diseases, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
ArriVent BioPharma investors
Foresite Capital Management, LLCMulti-stage healthcare and life sciences investor using data science to back companies at…their site
Hongshan Capital Advisors LimitedBacks transformative technologies, disruptive business models, and high-growth potential…their site
No round dates are on record for ArriVent BioPharma. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed ArriVent BioPharma are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.